Search research articles
Contact Us
Filters
Showing results (101-110 of 126) with videos related to
Page
of 13
Sort By:
Biomaterials
|
August 20, 2013
Bladder tissue regeneration using acellular bi-layer silk scaffolds in a large animal model of augmentation cystoplasty
Duong D Tu, Yeun Goo Chung, Eun Seok Gil, et al.
Current Oncology (Toronto, Ont.)
|
January 5, 2019
Hypertension as a predictor of advanced colorectal cancer outcome and cetuximab treatment response
S Sud, C O'Callaghan, C Jonker, et al.
Breast Cancer Research and Treatment
|
January 12, 2011
A randomized, placebo-controlled trial (NCIC CTG MAP.2) examining the effects of exemestane on mammographic breast density, bone density, markers of bone metabolism and serum lipid levels in postmenopausal women
T Cigler, H Richardson, M J Yaffe, et al.
Current Oncology (Toronto, Ont.)
|
May 3, 2019
The economic impact of the transition from branded to generic oncology drugs
W Y Cheung, E A Kornelsen, N Mittmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 28, 2002
Prophylaxis of radiation-associated mucositis in conventionally treated patients with head and neck cancer: a double-blind, phase III, randomized, controlled trial evaluating the clinical efficacy of an antimicrobial lozenge using a validated mucositis scoring system
S El-Sayed, A Nabid, W Shelley, et al.
Frontiers in Pediatrics
|
July 19, 2018
Vesicoamniotic Shunting Improves Outcomes in a Subset of Prune Belly Syndrome Patients at a Single Tertiary Center
Jeffrey T White, Kunj R Sheth, Aylin N Bilgutay, et al.
Frontiers in Pediatrics
|
August 25, 2018
Corrigendum: Vesicoamniotic Shunting Improves Outcomes in a Subset of Prune Belly Syndrome Patients at a Single Tertiary Center
Jeffrey T White, Kunj R Sheth, Aylin N Bilgutay, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 3, 2012
Impact of premenopausal status at breast cancer diagnosis in women entered on the placebo-controlled NCIC CTG MA17 trial of extended adjuvant letrozole
P E Goss, J N Ingle, S Martino, et al.
Investigational New Drugs
|
October 15, 2018
Canadian Cancer Trials Group (CCTG) IND215: A phase Ib study of Selumetinib in patients with untreated advanced or metastatic NSCLC who are receiving standard chemotherapy regimens
J R Goffin, G Nicholas, M Mates, et al.
Journal of Pediatric Urology
|
May 20, 2021
Urodynamic characteristics of neurogenic bladder in newborns with myelomeningocele and refinement of the definition of bladder hostility: Findings from the UMPIRE multi-center study
Stacy T Tanaka, Elizabeth B Yerkes, Jonathan C Routh, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 126) with videos related to
Sort By:
Page
of 13
Biomaterials
|
August 20, 2013
Bladder tissue regeneration using acellular bi-layer silk scaffolds in a large animal model of augmentation cystoplasty
Duong D Tu, Yeun Goo Chung, Eun Seok Gil, et al.
Current Oncology (Toronto, Ont.)
|
January 5, 2019
Hypertension as a predictor of advanced colorectal cancer outcome and cetuximab treatment response
S Sud, C O'Callaghan, C Jonker, et al.
Breast Cancer Research and Treatment
|
January 12, 2011
A randomized, placebo-controlled trial (NCIC CTG MAP.2) examining the effects of exemestane on mammographic breast density, bone density, markers of bone metabolism and serum lipid levels in postmenopausal women
T Cigler, H Richardson, M J Yaffe, et al.
Current Oncology (Toronto, Ont.)
|
May 3, 2019
The economic impact of the transition from branded to generic oncology drugs
W Y Cheung, E A Kornelsen, N Mittmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 28, 2002
Prophylaxis of radiation-associated mucositis in conventionally treated patients with head and neck cancer: a double-blind, phase III, randomized, controlled trial evaluating the clinical efficacy of an antimicrobial lozenge using a validated mucositis scoring system
S El-Sayed, A Nabid, W Shelley, et al.
Frontiers in Pediatrics
|
July 19, 2018
Vesicoamniotic Shunting Improves Outcomes in a Subset of Prune Belly Syndrome Patients at a Single Tertiary Center
Jeffrey T White, Kunj R Sheth, Aylin N Bilgutay, et al.
Frontiers in Pediatrics
|
August 25, 2018
Corrigendum: Vesicoamniotic Shunting Improves Outcomes in a Subset of Prune Belly Syndrome Patients at a Single Tertiary Center
Jeffrey T White, Kunj R Sheth, Aylin N Bilgutay, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 3, 2012
Impact of premenopausal status at breast cancer diagnosis in women entered on the placebo-controlled NCIC CTG MA17 trial of extended adjuvant letrozole
P E Goss, J N Ingle, S Martino, et al.
Investigational New Drugs
|
October 15, 2018
Canadian Cancer Trials Group (CCTG) IND215: A phase Ib study of Selumetinib in patients with untreated advanced or metastatic NSCLC who are receiving standard chemotherapy regimens
J R Goffin, G Nicholas, M Mates, et al.
Journal of Pediatric Urology
|
May 20, 2021
Urodynamic characteristics of neurogenic bladder in newborns with myelomeningocele and refinement of the definition of bladder hostility: Findings from the UMPIRE multi-center study
Stacy T Tanaka, Elizabeth B Yerkes, Jonathan C Routh, et al.
Page
of 13